ARCHIVES

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

More Bad News for AVEO As Tivozanib Partner Bids Adieu

May 31, 2013

Hollings Cancer Center at MUSC Wins NCI Designation

March 6, 2009

Abrams, Tomaszewski To Co-Direct DCTD

June 10, 2011

ODAC Chairman: Time Was Tight For Meeting

November 10, 1995

DCPC Advisors Okay Omnibus Prevention Program Announcement

January 24, 1992

New NCI Journal Patterned On “Science”

March 20, 1987